[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)

Clinical trial NCT02562989 · COMPLETED

Trial details

NCT number: NCT02562989
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease Amnestic Mild Cognitive Impairment

Start date: 2015-10-19
Primary completion: 2016-12-27
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.